Insys Therapeutics, Inc. to Present at J.P. Morgan
Post# of 301275
PHOENIX, Jan. 04, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ: INSY ) today announced that Santosh Vetticaden, MD, PhD, Senior Vice President and Chief Medical Officer, and Darryl Baker, Chief Financial Officer, will present at the J.P. Morgan 35 th Annual Healthcare Conference as follows:
| Date: | Monday, January 9, 2017 | ||
| Time: | 4:00 p.m. Pacific Standard Time | ||
| Location: | Westin St. Francis Hotel, San Francisco |
The presentation will be webcast live at the aforementioned time as well as archived for 90 days thereafter, via the Company’s website at www.insysrx.com , under the Investors Section or at http://jpmorgan.metameetings.com/confbook/hea...nk?p=22495 .
About Insys Therapeutics, Inc. Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of life of patients.
Investor Contact: Lisa M. Wilson Email: lwilson@insitecony.com
(0)
(0)